Kairui Bio

可瑞生物

Kairui Bio

Biotech/Healthcare

Kerui Biotech develops cancer immunotherapy technologies, focusing on innovative drugs based on T-cell receptors (TCRs). It has built a systematic biotechnology-based TCR R&D platform that addresses technical challenges in TCR cloning and optimization, helping pharmaceutical research institutions…

Latest round: Pre Series A (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-10-01